Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SBFM stock hub

Sunshine Biopharma, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SBFMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SBFM

In the news

Latest news · SBFM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-25.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-11.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SBFM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001402328
Company name	Sunshine Biopharma, Inc.
Country	United States
Country code	US
Cusip	867781304
Employees	50
Employees Change	-2%
Employees Change Percent	-3.85
Enterprise value	$-3.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	US8677817004
Last refreshed	2026-05-10
Market cap	$5.2M
Market cap category	Nano-Cap
Price	$1.05
Price currency	USD
Rev Per Employee	726,117.82x
Sector	Healthcare
Sic	2834
Symbol	SBFM
Website	https://sunshinebiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-116%
FCF yield	-106.88%
P/B ratio	0.22x
P/S ratio	0.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-12.34%
EBITDA Margin	-11.42%
Gross margin	33.76%
Gross Profit	$12.3M
Gross Profit Growth	14.86%
Gross Profit Growth Q	-2.08%
Gross Profit Growth3 Y	93.31%
Gross Profit Growth5 Y	206.16%
Net Income	$-6M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-16.4%
Profit Margin	-16.46%
Profit Per Employee	$-119,507
ROA	-9.23
Roa5y	-32.15
ROCE	-18.95
ROE	-25.68
ROIC	-11.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-76.11%
Cagr15y	-70.52%
Cagr1y	-17.33%
Cagr3y	-90.01%
Cagr5y	-88.57%
EPS Growth Years	0
Revenue Growth	4.11x
Revenue Growth Q	-10.61x
Revenue Growth Years	6x
Revenue Growth3 Y	102.91x
Revenue Growth5 Y	247.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.2
Assets	$30.1M
Cash	$9.1M
Current Assets	$26.9M
Current Liabilities	$6.4M
Debt	$812,422
Debt Equity	$0.04
Equity	$23M
Liabilities	$7M
Long Term Assets	$3.2M
Long Term Liabilities	$596,785
Net Cash	$8.3M
Net Cash By Market Cap	$161
Net Cash Growth	-4.84%
Net Debt Equity	$-0.36
Tangible Book Value	$21.1M
Tangible Book Value Per Share	$4.31
WACC	10.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.17
Inventory Turnover	1.94
Net Working Capital	$11.5M
Quick ratio	1.95
Working Capital	$20.4M
Working Capital Turnover	$1.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-492.39%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-17.32%
200-day SMA	1.36
3Y total return	-99.9%
50-day SMA	1.06
50-day SMA vs 200-day SMA	50under200
5Y total return	-100%
All Time High	230,158,730.2
All Time High Change	-100%
All Time High Date	2011-08-02
All Time Low	0.95
All Time Low Change	10.53%
All Time Low Date	2026-04-30
ATR	0.05
Beta	1.49
Beta1y	1.93
Beta2y	1.59
Ch YTD	-14.63
High	1.09
High52	2.43
High52 Date	2025-10-16
High52ch	-56.79%
Low	1.03
Low52	0.95
Low52 Date	2026-05-01
Low52ch	10.53%
Ma50ch	-0.66%
Price vs 200-day SMA	-22.51%
RSI	51.7
RSI Monthly	37.14
RSI Weekly	32.72
Sharpe ratio	-0.11x
Sortino ratio	-0.06
Total Return	-492.39%
Tr YTD	-14.63
Tr15y	-100%
Tr1m	0.96%
Tr1w	-0.47%
Tr3m	-12.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.16
Earnings Revenue Estimate	9,200,000x
Earnings Revenue Estimate Growth	3.36x
Operating Income	$-4.5M
Operating margin	-12.34
Price target	$7
Price Target Change	$567

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,803,972%
Float Percent	97.92%
Shares Insiders	2.08%
Shares Institutions	9.02%
Shares Out	4,905,945
Shares Qo Q	6.51%
Shares Yo Y	492.39%
Short Float	2.8%
Short Ratio	3.99
Short Shares	2.74

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-5.5M
Average Volume	35,877.7x
Bv Per Share	4.69
CAPEX	$-174,491
Ch10y	-100
Ch15y	-100
Ch1m	0.96
Ch1w	-0.47
Ch1y	-17.32
Ch3m	-12.5
Ch3y	-99.9
Ch5y	-100
Ch6m	-38.95
Change	-2.78%
Change From Open	-2.78
Close	1.08
Days Gap	0
Depreciation Amortization	332,070
Dollar Volume	29,761.2
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-4.5M
EBITDA	$-4.1M
EPS	$-1.44
F Score	3
FCF	$-5.5M
FCF EV Yield	174.25x
FCF Per Share	$-1.12
Financing CF	4,748,408
Fiscal Year End	December
Founded	2,006
Income Tax	$21,609
Investing CF	-836,306
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-03
Last Report Date	2025-12-31
Last Split Date	2024-08-08
Last Split Type	Reverse
Last10k Filing Date	2026-04-03
Ma150	1.32
Ma150ch	-20.33%
Ma20	1.02
Ma20ch	3.45%
Net CF	-563,221
Next Earnings Date	2026-05-22
Open	1.08
Optionable	No
Position In Range	33.33
Post Close	1.05
Postmarket Change Percent	2.61
Postmarket Price	$1.08
Ppne	1,336,216
Price Date	2026-05-08
Ptbv Ratio	0.24
Relative Volume	0.79x
Revenue	36,305,891x
Tax By Revenue	0.06x
Tr6m	-38.95%
Us State	Florida
Volume	28,344
Z Score	-1.42

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SBFM pay a dividend?

Capital-return profile for this ticker.

Performance

SBFM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SBFM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.0%

Float: +97.9% of shares outstanding

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SBFM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.7

Neutral momentum band

Price vs 200-day MA

-22.5%

50/200-day relationship not available

Beta (5Y)

1.49

More volatile than the market

Sharpe ratio

-0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SBFM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SBFM stock rating?

Sunshine Biopharma, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SBFM analysis?

The full report lives at /stocks/SBFM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SBFM?

The latest report frames SBFM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SBFM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.